Contents
Nvidia, Walmart, Crypto Stocks Lead Major Midday Moves
Biggest Midday Stock Movers: Nvidia, Walmart, Crypto and Pharma
Several major stocks experienced significant price changes midway through Thursday trading as earnings reports and regulatory decisions shaped market sentiment.
AI and Semiconductors
- Nvidia — dropped nearly 2%, reversing earlier gains, despite beating expectations for its fiscal third-quarter results and providing stronger-than-expected revenue guidance for the next quarter.
- Palantir Technologies — down nearly 6% as AI-related names declined alongside Nvidia.
- AMD — down 5%.
- Super Micro Computer — down 5%.
Crypto-Linked Stocks
Cryptocurrency-linked assets saw declines as Bitcoin’s value slid further and hopes for interest rate cuts diminished.
- Strategy — a Bitcoin treasury-focused company, lost almost 7%.
- Robinhood Markets — fell about 9%.
- Coinbase — slipped 7%.
- Circle Internet — down approximately 6%.
Pharma and Biotech
- Regeneron — shares climbed 4% after the U.S. Food and Drug Administration approved Eylea HD as a treatment for macular edema following retinal vein occlusion.
Retail
- Walmart — jumped nearly 6% after reporting stronger-than-expected third-quarter earnings. The retail giant posted adjusted earnings per share of 62 cents on $179.5 billion in revenue, surpassing analysts’ forecasts, and raised its full-year sales outlook.
Cybersecurity and Cloud
- Palo Alto Networks — dipped more than 6% following its announcement to acquire cloud management specialist Chronosphere for $3.35 billion, despite delivering fiscal first-quarter earnings that exceeded Wall Street expectations.
Beauty and Wellness
- Oddity — surged 11% on better-than-anticipated third-quarter results and an upgraded earnings forecast. Adjusted earnings reached 40 cents per share on $148 million in revenue, topping analyst expectations.
Engineering and Construction
- Jacobs Solutions — fell 9% despite outperforming earnings estimates for the fiscal fourth quarter and offering a strong outlook for fiscal 2026.
Healthcare
- Solventum — rose 4% after announcing the purchase of Acera Surgical for $725 million, moving into regenerative wound care markets.
Consumer and Specialty Retail
- Bath & Body Works — tumbled over 25% as third-quarter results missed analyst predictions, with adjusted earnings of 35 cents per share and $1.59 billion in revenue, below consensus forecasts.
